BCR and chronic myelogenous leukemia, BCR-ABL1 positive: The major breakpoint cluster region (M-BCR) that is involved transformation of CML from the chronic to the blastic phase was shown to undergo various levels of hypomethylation related to lymphoid-crisis patients studied in blastic phase.